Scinovex
articleTop 1% cited

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology · 2019 · Vol. 30(8) · pp. 1194–1220
Fátima CardosoS. KyriakidesShinji OhnoFrédérique Penault‐LlorcaPhilip PoortmansIsabel T. RubioSophia ZackrissonElżbieta Senkus
Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesMedicineBreast cancerClinical PracticeCancerOncologyFamily medicineInternal medicine

MeSH terms

AftercareBreast NeoplasmsEuropeEuropean UnionFemaleHumansMaleMedical OncologyPatient Care TeamRisk FactorsSocieties, MedicalIncidenceBreast Neoplasms, MaleEarly Detection of Cancer

Funding

  • AstraZeneca
  • GlaxoSmithKline
  • Eisai
  • European Society for Medical Oncology
  • Genentech
  • Merck Sharp and Dohme
Citations
2,185
FWCI
73.11
field-weighted impact
References
215
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.